The last three digits represent the section of the 34 act under which the filer is obligated to file periodic reports. Polymedix defaults and hands over a phii antibiotic to. All pdf documents must be submitted alongside their html or ascii counterpart. If youre not satisfied, return this product to quicken within 30 days of purchase with your dated receipt for a full refund of the purchase price less. A more complete description of these risk factors is included in polymedixs filings with the securities and exchange commission. Investor relations inmedix, innovative medical discovery. Cellceutix has prioritized to complete this process and submit the application to the fda.
The company was founded in 2002 and is based in radnor, pennsylvania. As a result of being a development stage company in a very early stage of product development with no revenues, the representative group of companies has certain similar, but not all similar, characteristics to the company. For our first patented project, fibromyalgia fm, we conducted three clinical studies, including a randomized, placebocontrolled trial negotiated with the fda, prior to monetizing the value of our research with an international patent portfolio sale. Under the securities exchange act of 1934 amendment no.
If one of these drugs failed, it would severely affect polymedixs stock price and investor confidence. Sec filings cormedix prevention of cardiac, renal and. Open report of unscheduled material events or corporate event in pdf file. Cellceutix acquires polymedix assets from bankruptcy court. Meltzer pepper hamilton llp hercules plaza suite 5100, n. Prior to polymedixs bankruptcy, the company had communicated with the u. Syndax the meeting will be held on may 23, 2018 at 2. The following table sets forth, as of the date of this prospectus, the name of each selling stockholder for whom we are registering shares for resale to the public, and the number of shares of common stock that each selling stockholder may offer pursuant to this prospectus. In the setting of an autoimmune disease, ans stress can significantly intensify an autoimmune disease. Radnor chester rd suite 300 radnor, pa 19087 delawarepa 4845982400 tax id ein. Following a due diligence process, cellceutix submitted a stalking horse bid for the polymedix assets in august. On wednesday, september 4, the bankruptcy court for the district of delaware approved the asset purchase agreement. This is the companys official address listed in sec filings. Quick reference guide to saving the authentication.
For example, the paper form 15 is implemented on edgar as a number of different submission types including. District court for the eastern district of pennsylvania, on behalf of purchasers of polymedix, inc. You should not place undue reliance on any forwardlooking. Sec form 20is information statement 2019 definitive information statement. Pymxq is delinquent in its periodic filings with the. Company results links open in a new window date document was filed at companies house type description of the document filed at companies house view download pdf file, link opens in new window. Securities and exchange commission reporting information.
Zynerba pharmaceuticals reports third quarter 2015. Documents may currently be submitted to the sec via the edgar filing system in html, ascii, pdf or xbrl format. All content is posted anonymously by employees working at polymedix. Variable insurance products by name of insurance company. Company or fund name, ticker symbol, central index key cik, file number, state, country, or standard industrial classification sic mutual fund name, ticker symbol, or sec key, since february 2006. You are cordially invited to attend the 2018 annual meeting of stockholders of syndax pharmaceuticals, inc. Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Pdf documents are accepted but considered unofficial submissions. This court has jurisdiction over the subject matter of this action under 28 u.
Registered office address changed from 4 church green east redditch worc. Polymedix pmx30063 defensinmimetic antibiotic compound. Polymedix, inc securities registration statement s1 selling stockholders. Cellceutix corporation signed a lease extension agreement with cummings properties, which began on october 1, 20.
Learn about working at polymedix, inc join linkedin today for free. This page provides links to pdf versions of sec public forms and many of the rules, regulations, and schedules associated with these forms. Quicken for mac imports data from quicken for windows 2010 or newer, quicken for mac 2015 or newer, quicken for mac 2007, quicken essentials for mac, banktivity. Cellceutix completes acquistion of polymedix assets. Edt at cooley llp, 1114 avenue of the americas, 46th floor, new york, new york 10036.
Our approach focuses on autonomic nervous system ans control of stress responses within the brain. Quarterly report which provides a continuing view of a companys financial position. Zyne, a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today reported financial results for the quarter ended september 30, 2015, and provided. Investors cormedix prevention of cardiac, renal and.
Moreover, the five respondents have failed to heed delinquency letters sent to them by the division of corporation finance. Cellceutix provides insights to its four clinical trials. Business overview polymedica corporation was organized in 1988 and has been in the business of acquiring and growing medical product and pharmaceutical businesses for over 15 years. These instructions are written to assist filers in the preparation and process of filing electronically. The lease is for a term of five years ending on september 30, 2018, and. Polymedix, inc securities registration statement s1. Year trailing 12months 2020 2019 2018 2017 2016 2015 2014 20 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994. Food and drug administration fda and was near completion of an investigational new drug application to move the drug into a phase 2 trial for oral mucositis. Survey of 2008 life sciences private investment in public. You can search information collected by the sec using a variety of search tools. To find a form, either select the appropriate category below or scroll through the full list of sec forms in alphanumeric order. The following is an excerpt from a 10k sec filing, filed by polymedica corp on 6142004. Polymedix defaults and hands over a phii antibiotic to bankruptcy court.
Sterimedix limited filing history free information from. Trial tests if hydroxychloroquine can protect healthcare workers from covid19. Edgar public dissemination service pds information for edgar filers. Careful planning for success inmedix specializes in understanding how stress drives an autoimmune disease to excess. B98 8bt to one fleet place london ec4m 7ws on 16 december 2015. Survey of 2008 life sciences private investment in public equity pipe transactions. Screenshots of actual 10k and 10q sec filings in pdf, word and excel formats. Saving the authentication document as a pdf file in. United states district court others similarly situated, v. Polymedix filed for chapter 7 bankruptcy protection on april 1, 20. Commission sec filings, wire and press releases published by and regarding cormedix, inc. Export annual and quarterly reports to adobe pdf, microsoft word and excel for offline viewing, annotations and analysis. A securities class action lawsuit was filed on july 2, 2012, in the u. Corporate offices 207a perry parkway, suite 1 gaithersburg, md 20877.
976 156 520 643 295 1180 1140 801 1573 1325 305 699 425 658 910 246 276 446 125 715 380 373 249 33 406 1326 531 649 536 954 239 485 647 406